BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 6192904)

  • 1. Intratumor immunologic heterogeneity.
    Miller FR
    Cancer Metastasis Rev; 1982; 1(4):319-34. PubMed ID: 6192904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Rous sarcoma virus-induced tumor antigens by cytotoxic T lymphocytes (CTL): studies on specificity of killing by CTL employing H-2 congenic and recombinant mouse tumor cells.
    Haraguchi S; Kurakata S; Fujii T; Matsuo T; Yoshida TO
    Cell Immunol; 1987 Apr; 105(2):340-54. PubMed ID: 2436809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].
    Lobko GN; Porubova GM
    Eksp Onkol; 1989; 11(1):69-71. PubMed ID: 2466634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of tumorigenicity phenotype in murine tumors. Characterization of tumor clones isolated from primary 3-methylcholanthrene-induced fibrosarcomas.
    Schmitt M; Daynes RA
    Transplantation; 1982 Apr; 33(4):387-92. PubMed ID: 6176054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antigenic divergence of tumor cells due to the expression of hetero-organic antigens as a manifestation of disordered differentiation in carcinogenesis].
    Fel' VIa
    Tsitologiia; 1990; 32(5):407-21. PubMed ID: 2275013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell diversity and host responses in cancer metastasis--part II--host immune responses and therapy of metastases.
    Nicolson GL; Poste G
    Curr Probl Cancer; 1983 Jan; 7(7):1-42. PubMed ID: 6340978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor.
    Miller FR; Heppner GH
    J Natl Cancer Inst; 1979 Dec; 63(6):1457-63. PubMed ID: 229294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between neoplasm and histocompatibility H-2 antigens].
    Strzadała L; Radzikowski C
    Postepy Hig Med Dosw; 1980; 34(2):107-18. PubMed ID: 7017638
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic heterogeneity of antisyngeneic tumor killer cells (ASTK) generated in allogeneic mixed lymphocyte reactions.
    Macphail S; Paciucci PA; Stutman O
    J Immunol; 1984 Jun; 132(6):3205-10. PubMed ID: 6144708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement.
    Manson LA
    Clin Immunol Immunopathol; 1994 Jul; 72(1):1-8. PubMed ID: 8020182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.
    Höglund P; Ljunggren HG; Kärre K; Jay G
    Immunol Res; 1990; 9(4):298-313. PubMed ID: 2089075
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
    Garrido ML; Pérez M; Delgado C; Rojano J; Algarra I; Garrido A; Garrido F
    J Immunogenet; 1986; 13(2-3):159-67. PubMed ID: 3819450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunology.
    Naftzger C; Houghton AN
    Curr Opin Oncol; 1991 Feb; 3(1):93-9. PubMed ID: 2043699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic tumor cell variants obtained with mutagens.
    Boon T
    Adv Cancer Res; 1983; 39():121-51. PubMed ID: 6353885
    [No Abstract]   [Full Text] [Related]  

  • 18. A heterophile system in human renal transplantation. IX. Comparison of heterophile transplantation antibodies to antivascular endothelial cell antibodies.
    Rohr MS; Gelder FB; Jacobbi LM; McDonald JC
    Transplantation; 1980 Aug; 30(2):103-6. PubMed ID: 6163235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumor.
    Rogers MJ; Law LW; Pierotti MA; Parmiani G
    Int J Cancer; 1980 Jan; 25(1):105-9. PubMed ID: 7399738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speculations on the role of major transplantation antigens in cell-mediated immunity against intracellular parasites.
    Zinkernagel RM
    Curr Top Microbiol Immunol; 1978; 82():113-38. PubMed ID: 83220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.